New York, NY (PRWEB) April 21, 2016
IVAO, an international organization with offices in San Francisco, California, is organizing an international conference titled «Biomedical Innovations for Healthy Longevity» aging and longevity research, where top thought academic thought leaders and industry executives from all over the world will convene for three days to present latest research results, discuss translational and commercialization opportunities, establish valuable collaborations, network and partner.
The event features a business forum with one day dedicated to round table discussions on presenting favorably presenting aging research in the press, novel ways to attract funding and classifying aging and many
At the conference IVAO plans to announce a roadmap for investing over $1 billion into a broad range of projects, companies and financial instruments linked to longevity research.
«After millennia of failed promises, we are finally reaching the point in human evolution, where major breakthroughs contributing to the body of knowledge in aging are happening almost every month in laboratories all over the world. We decided to combine the best features of mutual funds, venture capital firms and analytical companies in one place to build a reasonably conservative investment vehicle to take part in the coming longevity boom," said Andrey Fomenko, founder of IVAO.
The conference will transpire from the 25th to 28th of April at Grand Europa Hotel in St. Petersburg with some of the most promising and innovative scientists and companies
«Since 1995 Andrey Fomenko and I are monitoring research activities in aging and longevity. When in 1996 we established our
Scientists, industry executive, investors and students are invited to attend the conference and network with the most advanced professionals in aging and longevity to help advance the entire field.
IVAO provides a platform to link scientists, business people, funding bodies and general public to advance aging research with a conservative business model and investments that yield attractive returns while minimizing risk through careful screening and hedging strategies. This portal will integrate years of careful research and analysis with a social network, investment vehicle and even a range of life extension strategies. IVAO will be gradually evolving the system to make it into a tool of choice for venture capitalists, hedge funds as well as companies, laboratories and even individual scientists. For more information, please visit: http://www.ivao.com